ARTICLES BY THIS AUTHOR
- 6/2/2021
Hikma launches estradiol valerate injection
Estradiol valerate injection had a market value of roughly $16 million in the 12 months ending March 2021, according to IQVIA. - 6/2/2021
Zydus Cadila receives tentative FDA OK for generic Tagrisso
Zydus Cadila's osimertinib provides a generic treatment for lung cancer. - 6/1/2021
NCPA lauds Tennessee governor for signing PBM bill into law
The legislation prohibits PBMs from reimbursing pharmacies below their acquisition costs, among other provisions. - 6/1/2021
Hy-Vee dietitians offer free virtual nutrition store tours in Spanish
Hy-Vee also is offering individual dietitian services in Spanish through its virtual dietitian platform. - 6/1/2021
NCPA survey: Tight labor market squeezing local pharmacies
NCPA’s recent survey of independent pharmacists found that 80% of local pharmacies can’t find workers. - 6/1/2021
Camber intros generic Banzel
Camber's rufinamide tablets are used with other medications to control seizures in people who have Lennox-Gastaut syndrome. - 5/31/2021
Moderna applies for full FDA approval of its COVID-19 vaccine
Moderna's mRNA vaccine is currently on the U.S. market under an emergency use authorization, which was granted by the Food and Drug Administration in December. - 5/31/2021
Hikma debuts labetalol hydrochloride in dextrose injection, sodium chloride injection
Labetalol HCl injection, 100 mg/20 ml and 200 mg/40 ml vial had a market value of approximately $6 million in the 12 months ended March 2021, according to IQVIA. - 5/31/2021
AAM releases ‘Voices of Access’ report
The report from the Association for Accessible Medicines highlights the impact that accessible generic and biosimilar medicines have had on patients nationwide. - 5/31/2021
Hy-Vee offering COVID-19 vaccine incentives
The retailer is offering a $10 gift card to those who complete their COVID-19 vaccination at one of its pharmacies or pop-up vaccination clinics.